BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients

Fernando Pérez-Calvo, Francisco Jover-Diaz, Elisabet Delgado-Sánchez, Jorge Peris-García, María Ángeles Bernabéu-Martínez · 2025

Read BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients by Fernando Pérez-Calvo, Francisco Jover-Diaz, Elisabet Delgado-Sánchez, Jorge Peris-García, María Ángeles Bernabéu-Martínez (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12699972.txt.

Description

Pérez-Calvo and four co-authors reported results in twenty twenty-five from switching HIV patients to a three-drug single tablet. The BIKSWITCH study covered adults whose virus was controlled on older regimens not based on integrase inhibitors. The new tablet combines bictegravir with two standard backbone drugs.

Seventy-nine people switched and were checked after twenty-four weeks. The share with virus below the detection threshold rose from eighty-one percent at baseline to over ninety-two percent by the intention-to-treat count. Immune cell counts, kidney function, and blood fats held steady. Side effects appeared in about five percent of patients, and three stopped treatment because of them. The authors conclude the switch kept treatment effective and safe, matching the tablet's favorable profile.

Catalog record

CREATORFernando Pérez-Calvo, Francisco Jover-Diaz, Elisabet Delgado-Sánchez, Jorge Peris-García, María Ángeles Bernabéu-Martínez
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12699972

Browse the full library · About the Tower of Babel